Vericel (VCEL) Intangibles (2014 - 2026)
Vericel's (VCEL) quarterly Intangibles came in at $5.3 million in Q2 2026, down 10.53% year-over-year from $5.9 million in Q2 2025, and down 2.85% quarter-over-quarter from $5.5 million in Q1 2026.
Analysis
Vericel (VCEL) Intangibles (2014 - 2026) Analysis & Trends
Vericel has disclosed Intangibles across 8 years of filings, most recently posting $5.3 million for Q2 2026.
- In Q2 2026, Intangibles fell 10.53% year-over-year to $5.3 million; the TTM figure through Jun 2026 stood at $5.3 million (down 10.53% YoY), while the FY2025 annual figure was $5.6 million, down 10.0% from the prior year.
- Intangibles came in at $5.3 million for Q2 2026 at Vericel, down from $5.5 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $7.5 million in Q4 2022 to a low of $5.3 million in Q2 2026.
- Average Intangibles over 5 years is $6.4 million, with a median of $6.4 million recorded in 2024.
- Year-over-year, Intangibles slipped 8.33% in 2023 and decreased 10.53% in 2026.
- Over 5 years, Intangibles stood at $7.5 million in 2022, then dropped by 8.33% to $6.9 million in 2023, then decreased by 9.09% to $6.2 million in 2024, then slipped by 10.0% to $5.6 million in 2025, then decreased by 5.55% to $5.3 million in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $5.3 million in Q2 2026, $5.5 million in Q1 2026, and $5.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 330.24 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 62.10 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 2.55 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 30.61 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 5.31 Mn |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.31 Mn |
| Mar 31, 2026 | 5.47 Mn |
| Dec 31, 2025 | 5.63 Mn |
| Sep 30, 2025 | 5.78 Mn |
| Jun 30, 2025 | 5.94 Mn |
| Mar 31, 2025 | 6.09 Mn |
| Dec 31, 2024 | 6.25 Mn |
| Sep 30, 2024 | 6.41 Mn |
| Jun 30, 2024 | 6.56 Mn |
| Mar 31, 2024 | 6.72 Mn |
| Dec 31, 2023 | 6.88 Mn |
| Sep 30, 2023 | 7.03 Mn |
| Jun 30, 2023 | 7.19 Mn |
| Mar 31, 2023 | 7.34 Mn |
| Dec 31, 2022 | 7.50 Mn |
| Sep 30, 2016 | 2.71 Mn |
| Jun 30, 2016 | 2.78 Mn |
| Mar 31, 2016 | 2.85 Mn |
| Dec 31, 2015 | 2.92 Mn |
| Sep 30, 2015 | 2.99 Mn |